Two Sigma Investments’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,947
Closed -$49K 3017
2022
Q2
$49K Sell
19,947
-22,327
-53% -$104K ﹤0.01% 2349
2022
Q1
$342K Sell
42,274
-6,887
-14% -$70.4K ﹤0.01% 2169
2021
Q4
$654K Buy
49,161
+39,145
+391% +$984K ﹤0.01% 2985
2021
Q3
$437K Buy
10,016
+9,131
+1,032% +$394K ﹤0.01% 3370
2021
Q2
$37K Sell
885
-3,365
-79% -$148K ﹤0.01% 3951
2021
Q1
$206K Buy
4,250
+3,570
+525% +$208K ﹤0.01% 3616
2020
Q4
$67K Sell
680
-9,359
-93% -$820K ﹤0.01% 3240
2020
Q3
$693K Sell
10,039
-6,126
-38% -$535K ﹤0.01% 2006
2020
Q2
$1.71M Buy
16,165
+11,904
+279% +$1.41M 0.01% 1180
2020
Q1
$378K Sell
4,261
-2,873
-40% -$342K ﹤0.01% 2136
2019
Q4
$815K Buy
7,134
+4,281
+150% +$322K ﹤0.01% 2381
2019
Q3
$176K Sell
2,853
-1,237
-30% -$99K ﹤0.01% 3226
2019
Q2
$319K Buy
4,090
+3,262
+394% +$370K ﹤0.01% 2832
2019
Q1
$112K Sell
828
-1,336
-62% -$140K ﹤0.01% 2887
2018
Q4
$174K Sell
2,164
-1,507
-41% -$149K ﹤0.01% 2739
2018
Q3
$385K Buy
+3,671
New +$350K ﹤0.01% 2629
2018
Q1
Sell
-1,494
Closed -$250K 3651
2017
Q4
$250K Buy
+1,494
New +$383K ﹤0.01% 2817
2017
Q2
Sell
-687
Closed -$159K 3388
2017
Q1
$159K Buy
+687
New +$119K ﹤0.01% 2756

Other funds holding CALA

Two Sigma Investments's CALA Position: Q3 2022 in Review

Two Sigma Investments sold out of Calithera Biosciences, Inc (CALA) in Q3 2022, closing a stake of 19,947 shares — an estimated $49K sold.

Two Sigma Investments first reported a position in CALA in Q1 2017 and held it in 18 quarters. The position peaked at $1.71M in Q2 2020. 22 funds tracked by Wall St. Rank hold CALA as of Q3 2022.

  • Two Sigma Investments reported no remaining Calithera Biosciences, Inc position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Investments sold 19,947 Calithera Biosciences, Inc shares in Q3 2022, an estimated $49K.
  • Two Sigma Investments first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 18 quarters.
  • Two Sigma Investments's Calithera Biosciences, Inc position peaked at $1.71M in Q2 2020.
  • 22 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.